Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Kerr

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Australian and New Zealand Journal of Medicine|February 1, 1977
Imaging of acute myocardial infarction using technetium 99m labelled phosphate compoundsG D Kerr, A Pitt, C C Wong, et al.
BMJ (Clinical Research Ed.)|November 26, 1988
Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmaticsR A Nagel, P Brown, W H Perks, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
The correlation between acid suppression and peptic ulcer healingR H Hunt, C W Howden, D B Jones, et al.
Gut|September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugsD B Jones, C W Howden, D W Burget, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitisJ R B Green, J C Mansfield, J A Gibson, et al.
The Practitioner|August 1, 1980
Dydrogesterone in the treatment of the premenstrual syndromeG D Kerr, J B Day, M R Munday, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1992
Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 monthsJ R Green, C H Swan, A Rowlinson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1995
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trialG D Bell, C M Bate, A T Axon, et al.
Gut|February 14, 1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study GroupJ J Misiewicz, A W Harris, K D Bardhan, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Australian and New Zealand Journal of Medicine|February 1, 1977
Imaging of acute myocardial infarction using technetium 99m labelled phosphate compoundsG D Kerr, A Pitt, C C Wong, et al.
BMJ (Clinical Research Ed.)|November 26, 1988
Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmaticsR A Nagel, P Brown, W H Perks, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
The correlation between acid suppression and peptic ulcer healingR H Hunt, C W Howden, D B Jones, et al.
Gut|September 1, 1987
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugsD B Jones, C W Howden, D W Burget, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitisJ R B Green, J C Mansfield, J A Gibson, et al.
The Practitioner|August 1, 1980
Dydrogesterone in the treatment of the premenstrual syndromeG D Kerr, J B Day, M R Munday, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1992
Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 monthsJ R Green, C H Swan, A Rowlinson, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1995
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trialG D Bell, C M Bate, A T Axon, et al.
Gut|February 14, 1998
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study GroupJ J Misiewicz, A W Harris, K D Bardhan, et al.
Pageof 5